AdaptHealth (AHCO) Fundamental Analysis: Revenue, Earnings & Valuation

9.60 / 10

Outperform

Fundamental analysis scores 9.6/10, rated Outperform. Key strengths include PB‑ROE, Cash‑MV, Revenue‑MV and solid operating cash flow, delivering strong one‑month returns. However, EPS growth and total profit YoY are negative, tempering the otherwise promising outlook.

Analysis Checks(4/10)

Revenue-MV

Value1.53

Score2/3

Weight48.94%

1M Return3.24%

Net cash flow from operating activities per share (YoY growth rate %)

Value10.37

Score1/3

Weight11.32%

1M Return0.81%

PB-ROE

Value-0.75

Score2/3

Weight11.66%

1M Return0.81%

Basic earnings per share (YoY growth rate %)

Value-183.87

Score0/3

Weight-19.65%

1M Return-1.82%

Total profit (YoY growth rate %)

Value-111.14

Score0/3

Weight-34.40%

1M Return-3.20%

Net cash flow from operating activities (YoY growth rate %)

Value11.06

Score2/3

Weight21.95%

1M Return1.55%

Cash-UP

Value-0.03

Score0/3

Weight-54.55%

1M Return-4.87%

Diluted earnings per share (YoY growth rate %)

Value-185.25

Score0/3

Weight-18.86%

1M Return-1.72%

Asset-MV

Value-0.55

Score1/3

Weight21.79%

1M Return1.77%

Cash-MV

Value1.45

Score3/3

Weight111.79%

1M Return6.61%

Is AHCO undervalued or overvalued?

AHCO scores 9.60/10 on fundamentals and holds a Discounted valuation at present. Backed by its -4.56% ROE, -2.04% net margin, -21.50 P/E ratio, 1.00 P/B ratio, and -183.87% earnings growth, these metrics solidify its Outperform investment rating.